Inventor · disambiguated record
Franz-Josef Van Der Staay
Also filed as: BOESS FRANK-GERHARD · VAN DER STAAY FRANZ-JOSEF
25 granted patents·4 pending applications·413 citations·filing 1996–2018
96Inventor score
Top patents by PatentIndex Score
29 records- 0189US7488733B26-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitorsBOEHRINGER INGELHEIM INT·Filed 2004·Granted Feb 10, 2009·37 cites·8 claims
- 0289US5874438A2,2'-bridged bis-2,4-diaminoquinazolinesBAYER AG·Filed 1996·Granted Feb 23, 1999·57 cites·18 claims
- 0388US7615558B26-arylmethylprazolo[3,4-d]pyrimidinesBOEHRINGER INGELHEIM INT·Filed 2004·Granted Nov 10, 2009·31 cites·6 claims
- 0488US5866562ARing-bridged bis-quinolinesBAYER AG·Filed 1996·Granted Feb 2, 1999·55 cites·6 claims
- 0587US7795453B2Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsBAYER SCHERING PHARMA AG·Filed 2003·Granted Sep 14, 2010·19 cites·9 claims
- 0686US6573263B2Substituted imidazotriazinonesBAYER AG·Filed 2001·Granted Jun 3, 2003·29 cites·11 claims
- 0784US8153799B2Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsFLESSNER TIMO·Filed 2010·Granted Apr 10, 2012·6 cites·12 claims
- 0884US5760230A4, 4'-bridged bis-2, 4-diaminoquinazolinesBAYER AG·Filed 1996·Granted Jun 2, 1998·38 cites·7 claims
- 0983US6589949B13-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseasesBAYER AG·Filed 2000·Granted Jul 8, 2003·23 cites·10 claims
- 1082US5739127A2,4'-bridged bis-2,4-diaminoquinazolinesBAYER AG·Filed 1996·Granted Apr 14, 1998·36 cites·7 claims
- 1181US7022709B2Selective PDE 2 inhibitors as pharmaceuticals for improving perceptionBOESS FRANK-GERHARD·Filed 2001·Granted Apr 4, 2006·21 cites·2 claims
- 1279US8044060B26-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memoryBOEHRINGER INGELHEIM INT·Filed 2004·Granted Oct 25, 2011·11 cites·11 claims
- 1377US9067931B22-heteroaryl carboxamidesBAYER IP GMBH·Filed 2014·Granted Jun 30, 2015·2 cites·12 claims
- 1477US6998402B2Substituted imidazotriazinonesBAYER AG·Filed 2002·Granted Feb 14, 2006·11 cites·11 claims
- 1575US8772511B2Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsFLEΒNER TIMO·Filed 2012·Granted Jul 8, 2014·3 cites·20 claims
- 1674US9714242B2Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsBAYER IP GMBH·Filed 2014·Granted Jul 25, 2017·1 cites·26 claims
- 1773US10214524B22-heteroaryl carboxamidesBAYER IP GMBH·Filed 2015·Granted Feb 26, 2019·1 cites·13 claims
- 1872US5756517AUse of bisquinoline compounds in the treatment of cerebral disordersBAYER AG·Filed 1996·Granted May 26, 1998·18 cites·6 claims
- 1971US8809348B26-arylmethyl substituted pyrazolo[3,4-d]pyrimidinesHENDRIX MARTIN·Filed 2009·Granted Aug 19, 2014·1 cites·10 claims
- 2071US7977485B22-heteroaryl carboxamidesBAYER SCHERING PHARMA AG·Filed 2003·Granted Jul 12, 2011·3 cites·14 claims
- 2166US2019367504A1Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsBAYER IP GMBH·Filed 2018·Application pending·0 cites
- 2263US10196388B2Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonistsBAYER IP GMBH·Filed 2017·Granted Feb 5, 2019·0 cites·4 claims
- 2360US2011263591A12-heteroaryl carboxamidesBAYER SCHERING PHARMA AG·Filed 2011·Application pending·0 cites
- 2458US2009111838A16-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitorsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 2557US2012258964A12-heteroaryl carboxamidesLUITHLE JOACHIM·Filed 2012·Application pending·0 cites
- 2654US8642605B26-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidinesHENDRIX MARTIN·Filed 2011·Granted Feb 4, 2014·0 cites·3 claims
- 2750US8822479B26-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidinesHENDRIX MARTIN·Filed 2010·Granted Sep 2, 2014·0 cites·17 claims
- 2845US6174897B1Bis-(quinolyl)-diaminesBAYER AG·Filed 1996·Granted Jan 16, 2001·10 cites·3 claims
- 2929US6344471B12-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseasesBAYER AG·Filed 1999·Granted Feb 5, 2002·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Franz-Josef Van Der Staay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →